Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Aas, Inc., Pioneer in Portable PCR Diagnostics, Celebrated in this Year’s Nominet Trust 100
  • USA - English


News provided by

Aas, Inc

Dec 15, 2015, 03:00 ET

Share this article

Share toX

Share this article

Share toX


Onikepe Adegbola, MD PhD, CEO of Aas Inc: “We are proud and grateful to the Nominet Trust for recognizing our work.”

Post this

Halethorpe, MD (PRWEB) December 15, 2015 -- • Aas, Inc, a pioneer in portable PCR diagnostics, has been recognised by this year’s NT100, which celebrates projects using digital technology to tackle some of the most pressing global challenges of 2015
• Social innovators around the world are using a vast array of tech for good, from humanitarian drones to 3D-printing, and geo-location to social media
• At Aas we understand the amazing potential that PCR and other molecular diagnostic techniques have in global health. We also understand that those who need it the most are very often furthest from its reach. Our PCR devices and diagnostic assays are built to reach every corner of the world, democratizing PCR and other molecular diagnostic techniques for everyone.

Today, Nominet Trust, the UK’s leading tech for good funder, has announced that Aas, Inc has been named among the 2015 Nominet Trust 100 (NT100) – a global celebration of the 100 most inspiring uses of digital technology for social good.

Projects featured in the NT100 are using technology to tackle some of the world’s biggest social problems including support for refugees in Europe, healthcare, social inclusion and our emergency response to natural disasters.

Following a global call for nominations earlier this year Aas, Inc, a Maryland Biotechnology company, was selected by ten leading judging partners from the tech and charity world in recognition of our work. Aas is developing PCR enabled portable, easy to use, point of care diagnostics for global health.

Commenting on their inclusion in the NT100, Onikepe Adegbola, MD PhD, CEO of Aas Inc, added: “The goal of Aas is to provide solutions to global health problems. We are presently developing portable diagnostics using PCR to enable disease diagnosis not only in high technology settings, but also at the point of care in all settings globally. We are proud and grateful to the Nominet Trust for recognizing our work.”

This year, Aas, Inc is rubbing shoulders with familiar names such as Google X’s Project Loon, which aims to deliver the Internet to developing countries via large air balloons and Wayfindr, a project led by UK charity, the Royal London Society for Blind People (RLSB), which allows visually impaired people to navigate via an audio smartphone app. The list also features lesser-known ventures such as Kgolagano, which utilises TV white space to provide medical care to rural areas of Botswana remotely, and Humanitarian Open Street Maps Team, which harnesses the power of the crowd to build maps for emergency aid workers, for example during the West Africa Ebola outbreak.

Participation in the ‘tech for good’ movement continues to rise and the 2015 selection illustrates important long-term developments ranging from the bioprinting of human tissue models to eDemocracy platforms. It also features responses to more recent current affairs that have dominated news headlines, such as the huge influx of migrants to Europe.

Vicki Hearn, Director of Nominet Trust, said, “Remarkable people all over the world are embracing technology to combat some of the most pressing social challenges we face today. This year in particular, the resourcefulness of organisations helping those in urgent need is hugely inspirational. Initiatives supporting the communities devastated by the Ebola outbreak and the Nepal earthquake are powerful examples of how imaginative use of digital technology can enable us to respond swiftly to rapidly evolving crises. Increasing accessibility to technology is helping foster communities of social tech entrepreneurs worldwide, who are transforming healthcare, access to education, sustainability and civic empowerment. The NT100 seeks to highlight these pioneers, so that others may be encouraged to follow in their footsteps.”

The 2015 NT100 was compiled from a combination of over 500 public nominations and in-house research to produce a shortlist of 150 projects. This shortlist was presented to our judging partners of ten tech and charity organisations, who selected the final 2015 NT100. Representatives from Big Lottery Fund, Comic Relief, Creative England, Facebook, Latimer Group, Nominet, O2 Telefonica, Oxfam, Salesforce and Society Guardian all took part in the selection process.

Information about all of the projects is hosted on the Social Tech Guide (socialtech.org.uk), the world’s largest interactive index of tech for good, which now has almost 1,300 ventures in its database.
Follow the action @socialtechguide / #2015NT100.

admin(at)aasinc(dot)co
1-202-697-9755
1450 South Rolling Road
Halethorpe, MD 21227

For further information on the NT100 or Nominet Trust please contact:
Ellie Hale/Charlie Hamilton at
Albion Drive on behalf of Nominet Trust
Ellie(dot)hale(at)albiondrive(dot)com/charlie(dot)hamilton(at)albiondrive(dot)com
+44(0)20 7033 8914/+44(0)20 7033 8919

Onikepe Adegbola, MD PhD, Aas, Inc, http://www.aasinc.co, +1 (202) 697-9755, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.